Compare BigBearai Holdings Inc (BBAI) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BigBearai Holdings Inc vs Novavax Inc — how do they compare? BigBearai Holdings Inc trades at $3.34 (market cap $1.60B), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: BigBearai Holdings Inc is the larger of the two by market cap, and Novavax Inc is trading nearer its 52-week high, BigBearai Holdings Inc nearer its low. Which is the better fit depends on your goals.
| BBAI | NVAX | |
|---|---|---|
Market Cap | $1.60B | $1.31B |
Sector | Technology | Health |
52-Week High | $8.91 | $11.19 |
52-Week Low | $2.61 | $6.22 |
Enterprise Value | $1.30B | $889.30M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BigBearai Holdings Inc
BigBearai Holdings Inc is a specialized provider of AI-driven decision intelligence solutions, primarily serving the U.S. defense, intelligence, and national security communities. It operationalizes complex data into actionable insights through its core modules—Observe, Orient, and Dominate—to support mission-critical operations and logistics.
Read more on BBAI →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
